Although there was a significant absorption in the kidneys and liver, all other organs that frequently host primary breast cancer or metastases had very low background levels, resulting in an overall favorable 68Ga-HER2-NB biodistribution with minimal to no side effects observed. The gene discussed is ERBB2; the disease is breast carcinoma.